A detailed history of Barclays PLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Barclays PLC holds 219,942 shares of DGX stock, worth $30.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
219,942
Previous 471,395 53.34%
Holding current value
$30.2 Million
Previous $62.7 Million 52.02%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $31.7 Million - $36.3 Million
-251,453 Reduced 53.34%
219,942 $30.1 Million
Q1 2024

May 15, 2024

BUY
$123.78 - $142.11 $11.2 Million - $12.8 Million
90,244 Added 23.68%
471,395 $62.7 Million
Q4 2023

Feb 15, 2024

BUY
$120.62 - $141.12 $16.4 Million - $19.1 Million
135,687 Added 55.28%
381,151 $52.6 Million
Q3 2023

Nov 07, 2023

SELL
$121.86 - $144.92 $7.09 Million - $8.44 Million
-58,210 Reduced 19.17%
245,464 $29.9 Million
Q2 2023

Aug 03, 2023

BUY
$130.56 - $146.84 $11.1 Million - $12.5 Million
84,859 Added 38.78%
303,674 $42.7 Million
Q1 2023

May 04, 2023

SELL
$131.53 - $155.76 $16.1 Million - $19.1 Million
-122,647 Reduced 35.92%
218,815 $31 Million
Q4 2022

Feb 13, 2023

BUY
$123.31 - $157.26 $1.96 Million - $2.5 Million
15,885 Added 4.88%
341,462 $53.4 Million
Q3 2022

Nov 03, 2022

BUY
$121.77 - $141.1 $3.76 Million - $4.35 Million
30,838 Added 10.46%
325,577 $39.9 Million
Q2 2022

Aug 12, 2022

SELL
$127.07 - $145.39 $670,675 - $767,368
-5,278 Reduced 1.76%
294,739 $39.2 Million
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $1.71 Million - $2.18 Million
-13,281 Reduced 4.24%
300,017 $41.1 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $11.2 Million - $13.8 Million
-79,707 Reduced 20.28%
313,298 $54.2 Million
Q3 2021

Nov 09, 2021

BUY
$132.95 - $158.0 $6.93 Million - $8.23 Million
52,106 Added 15.28%
393,005 $57.1 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $9.5 Million - $10.6 Million
75,011 Added 28.21%
340,899 $45 Million
Q1 2021

May 13, 2021

BUY
$114.63 - $133.34 $2.13 Million - $2.48 Million
18,587 Added 7.52%
265,888 $34.1 Million
Q4 2020

Feb 11, 2021

BUY
$112.7 - $128.05 $8.66 Million - $9.84 Million
76,823 Added 45.06%
247,301 $29.5 Million
Q3 2020

Nov 12, 2020

BUY
$107.05 - $130.01 $8.67 Million - $10.5 Million
80,993 Added 90.51%
170,478 $19.5 Million
Q2 2020

Aug 12, 2020

SELL
$73.34 - $122.61 $2.01 Million - $3.36 Million
-27,374 Reduced 23.42%
89,485 $10.2 Million
Q1 2020

May 13, 2020

SELL
$75.14 - $115.68 $13.5 Million - $20.8 Million
-179,815 Reduced 60.61%
116,859 $9.38 Million
Q4 2019

Feb 10, 2020

BUY
$100.29 - $107.99 $9.24 Million - $9.95 Million
92,125 Added 45.04%
296,674 $31.7 Million
Q3 2019

Nov 14, 2019

SELL
$97.85 - $107.42 $2.29 Million - $2.51 Million
-23,366 Reduced 10.25%
204,549 $21.9 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $2.73 Million - $3.27 Million
32,046 Added 16.36%
227,915 $23.2 Million
Q1 2019

May 15, 2019

BUY
$80.68 - $89.92 $3.7 Million - $4.12 Million
45,836 Added 30.55%
195,869 $17.6 Million
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $15.5 Million - $21.1 Million
-194,380 Reduced 56.44%
150,033 $12.5 Million
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $15 Million - $16.3 Million
142,016 Added 70.17%
344,413 $37.2 Million
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $6.96 Million - $8.08 Million
-71,451 Reduced 26.09%
202,397 $22.3 Million
Q1 2018

May 15, 2018

BUY
$96.42 - $107.88 $3.61 Million - $4.04 Million
37,455 Added 15.84%
273,848 $27.5 Million
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $6.09 Million - $6.72 Million
67,036 Added 39.58%
236,393 $23.3 Million
Q3 2017

Nov 14, 2017

BUY
$91.96 - $108.35 $15.6 Million - $18.3 Million
169,357
169,357 $15.9 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.